IHU SEPSIS stands as the first global center devoted to integrated research, education, and patient care in sepsis, bringing together in a single institution a world-class hub for innovation across ...
The CDC acknowledges that sepsis is life-threatening, costly, and difficult to predict, diagnose, and treat. Providers agree. But consensus on how to address it remains elusive. Sepsis has an image ...
The management of sepsis in the critical care setting remains a formidable challenge, demanding an integrated approach that combines early detection, prompt therapeutic intervention and continuous ...
TOULOUSE, France & FULLERTON, Calif., November 12, 2025--(BUSINESS WIRE)--Regulatory News: ABIONYX Pharma, (FR0012616852 - ABNX - PEA PME eligible), a next-generation biopharma company pioneering a ...
Transformative alliance to Create the world-leading clinical infrastructure and breakthrough biotechnology to redefine the therapeutic landscape of sepsis. ABIONYX Pharma, (FR0012616852 - ABNX), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results